Abstract
No abstractReferences
WHO model list of essential medicines for children. Fifth edition. WHO; 2015. [Cited 2015 Nov 20]. Available from http://www.who.int/medicines/publications/essentialmedicines/ EMLc_2015_FINAL_amended_AUG2015.pdf?ua=1
Clément MC, Mahlaoui N, Mignot C, Le Bihan C, Rabetrano H, Hoang L, Neven B, Moshous D, Cavazzana M, Blanche S, Fischer A, Audrain M, Durand-Zaleski I. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data. J Allergy Clin Immunol. 2015;135:1589-93.
Ghosh S, Thrasher AJ, Gaspar HB. Gene therapy for monogenic disorders of the bone marrow. Br J Haematol. 2015 Jun 5. doi: 10.1111/bjh.13520 [Epub ahead of print]
Principles of care for primary immunodeficiencies. Font Immunol. [on line] 2014 Dec 14. [Cited 2015 Nov 20] Available from http://journal.frontiersin.org/article/10.3389/ fimmu.2014.00627/full
Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, Abel L. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33(1):1-7.
Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012;1250:62-72.
Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497-502.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2016 Revista Alergia México